Is generic fluoxetine effective?

Journal of Affective Disorders

Volumn 81, Issue 2, 2004, Pages 185-186

  Yu, Benjamin P ^a   Chong, Yun S ^a   Maguire, Gerald A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; FLUOXETINE; GENERIC DRUG; SEROTONIN UPTAKE INHIBITOR;

ANXIETY; BIOEQUIVALENCE; DEPRESSION; DIARRHEA; DRUG EFFICACY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; FOOD AND DRUG ADMINISTRATION; HEADACHE; HUMAN; LETTER; NERVOUSNESS; PRESCRIPTION; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME;

DEPRESSIVE DISORDER; FLUOXETINE; HEADACHE; HUMANS; RANDOMIZED CONTROLLED TRIALS; SEROTONIN UPTAKE INHIBITORS; THERAPEUTIC EQUIVALENCY; TREATMENT OUTCOME;

EID: 4043179106     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(03)00160-5     Document Type: Letter

References (5)

1. Bakish D., Miller C., Hooper C.L., Cavazzoni P., Thibaudeau C., Attwood D., Layton S. A double-blind, crossover study comparing generic and brand fluoxetine in the treatment of major depressive disorder. 2001;NCDEU
2. Finn R. Generic fluoxetine may offer lower bioequivalence. Clin. Psychiatry News. 30:(4):2002;18
3. Kaplan H.I., Sadock B.J. Kaplan and Sadock's Synopsis of Psychiatry. 8th Edition :1998;Lippincott-Willliams & Wilkins, New York
4. Lam Y.W., Ereshefsky L., Toney G.B., Gonzales C. Branded versus generic clozapine: bioavailability comparison and interchangeability issues. J. Clin. Psychiatry. 62:(Suppl. 5):2001;18-22. discussion 23-24
5. Mofsen R., Balter J. Case reports of the reemergence of psychotic symptoms after conversion from brand-name clozapine to a generic formulation. Clin. Ther. 23:(10):2001;1720-1731